Nevertheless, the study has notable strengths, especially in demonstrating how some patients may experience a prolonged disease course involving nearly all potential clinical and neuroradiological manifestations of CAA, including TFNEs, cSAH, CAA-related inflammation, ischemic stroke, and ICH. This evidence concerns the gene CMAHP and ischemic stroke.